Yes, HFMD Can Cause Lesions on the Face and Scalp
Hand, foot, and mouth disease (HFMD) can definitely cause lesions on the face and scalp, particularly in atypical presentations most commonly associated with coxsackievirus A6 (CVA6) infections. This represents a significant departure from the classic presentation limited to hands, feet, and mouth.
Atypical Distribution Patterns
The traditional understanding of HFMD as being confined to palms, soles, and oral mucosa is outdated. Modern evidence demonstrates:
- Face involvement occurs in approximately 45% of atypical HFMD cases 1
- Scalp lesions are well-documented, with one case report specifically describing a macular rash on the scalp in a 19-year-old patient with confirmed CVA6 infection 2
- Peri-oral rash is particularly associated with CVA6 (P < 0.001) 3
- Lesions on earlobes and faces were observed in prospective cohort studies 4
Morphologic Characteristics
When HFMD affects the face and scalp, the lesions can appear as:
- Vesicles (53% of atypical cases)
- Papules (49% of cases)
- Bullae (36% of cases)
- Maculopapular rashes
- Eczema herpeticum-like eruptions (19%) 1
The rash often starts on the face and then extends to other body areas 5.
Viral Etiology
CVA6 is identified in 63% of atypical HFMD cases 1, and this serotype has been specifically linked to widespread distribution patterns including facial involvement. However, CV-A16 can also cause generalized exanthema, though peri-oral involvement is more characteristic of CVA6 3.
Clinical Implications
Common Pitfalls to Avoid:
Misdiagnosis risk: The atypical morphologies and distribution can mimic other conditions (varicella, eczema herpeticum, drug eruptions), leading to unnecessary investigations, hospitalization, and inappropriate treatment 1
Age assumptions: While predominantly a childhood disease, HFMD occurs in adults with atypical presentations, so don't dismiss the diagnosis based on age alone 2, 6
Sample collection: According to diagnostic guidelines, vesicle fluid from facial lesions can be used for virus isolation and PCR confirmation, along with respiratory and stool samples 7
Expected Course
- Symptoms typically resolve in a mean of 10 days 1
- The disease is self-limiting
- Watch for delayed complications like onychomadesis (nail shedding) occurring approximately 3 weeks after symptom onset in 21% of cases 1, 5
- Desquamation may occur around 2 weeks post-infection 1
The key takeaway: facial and scalp involvement in HFMD is not rare or unusual—it's a recognized atypical presentation that has been increasingly reported worldwide since 2008, predominantly associated with CVA6 infections.